Aller au contenu
AwardGraph

Profil acheteur

Revmatologický ústav

CZ
Attributions
31
Montant total attribué
0 €
Pays
countries.CZ
Dernière attribution
13 juil. 2026
Expirent sous 12 mois
0

Historique des attributions

DateFournisseurIntituléMontantPaysExpirationSource
13/07/2026Avenier a.s.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – Mepolizumab 2026CZVoir sur TED
06/01/2026Janssen-Cilag s.r.o.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků - TREMFYA 2025CZVoir sur TED
06/01/2026PHARMOS, a.s.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – Filgotinib 2025 (JYSELECA)CZVoir sur TED
01/10/2025PROMEDICA PRAHA GROUP, a.s.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků - STOBOCLO 2025CZVoir sur TED
07/01/2025Janssen-Cilag s.r.o.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – SIMPONI 2024CZVoir sur TED
07/01/2025Janssen-Cilag s.r.o.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – REMICADE 2024CZVoir sur TED
08/11/2024PROMEDICA PRAHA GROUP, a.s.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – Etanercept - ERELZI 2024CZVoir sur TED
03/09/2024PROMEDICA PRAHA GROUP, a.s.Czechia – Medicinal products for the blood, blood-forming organs and the cardiovascular system – Dodávky léků - Bosentan 2024CZVoir sur TED
08/08/2024GlaxoSmithKline, s.r.o.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků - BELYSTA 2024 opakované VŘCZVoir sur TED
08/08/2024Fresenius Kabi s.r.o.Czechia – Antineoplastic and immunomodulating agents – „Dodávky léků – Tocilizumab 2024 - biosimilarCZVoir sur TED
06/06/2024Takeda Pharmaceuticals Czech Republic s.r.o.Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – HYQVIA 2024CZVoir sur TED
03/05/2024Czechia – Antineoplastic and immunomodulating agents – Dodávky léků – BELYSTA 2024CZVoir sur TED
09/01/2024Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
04/12/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
10/11/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
10/11/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
05/06/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
02/06/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
02/06/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
02/06/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
03/02/2023Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
05/12/2022Czechia-Prague: Diagnostic agentsCZVoir sur TED
07/09/2022Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
09/08/2022Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
01/07/2022Czechia-Prague: Diagnostic ultrasound devicesCZVoir sur TED
05/10/2021Czechia-Prague: Medicinal products for the musculo-skeletal systemCZVoir sur TED
10/09/2021Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
10/09/2021Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
02/06/2021Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
10/05/2021Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
03/05/2021Czechia-Prague: Antineoplastic and immunomodulating agentsCZVoir sur TED
Revmatologický ústav — profil acheteur — AwardGraph